-
venBio is a life sciences investment firm that partners with industry leaders to build game-changing medicines and technologies, with a focus on novel therapeutics for unmet medical needs. venBio manages both venture capital funds from San Francisco along with a long / short equity hedge strategy from New York City.
Latest News
-
2016
06MAYvenBio Closes $315 Million Life Sciences Venture Capital Fund
posted by admin in Latest NewsNew Venture Captial Fund Exceeds 250 million dollar expectation...
Read More -
2016
20APR -
2016
27MARBaxalta and Precision BioSciences form Global Genome Editing Collaboration in Immuno-Oncology
posted by admin in Latest NewsBaxalta and Precision BioSciences to utilize proprietary ARCUS genome editing...
Read More -
2016
15MARHeart Metabolics Announces Multiple Senior Appointments to Management Team
posted by admin in Latest NewsAll Functional Areas Strengthened to Support Advancement of the Clinical Pipeline...
Read More